BAD LETTUCE

Josie Doan/PitchBook

Agtech

AI can help spot ‘bad lettuce.’ That doesn’t make it a good business.

A summer of outbreaks hasn’t convinced VCs to fund a faddish problem.
BAD LETTUCE

Josie Doan/PitchBook

“Bad lettuce” has become the punchline of the summer, but don’t expect it to be the next big agtech opportunity.

Despite several simultaneous outbreaks of foodborne diseases across America—including cyclosporiasis, caused by a parasite that can spread through lettuce—founders and VCs say that building around detecting outbreaks is chasing a fad.

“It’s not a sustainable business because what happens when people stop writing articles about the bad lettuce? People stop spending money on the bad lettuce problem,” said Greg Yap, partner at Menlo Ventures, an investor in Clear Labs, a startup using AI to detect infectious diseases and foodborne illnesses. “Food safety is not going to go up and continue. It’s going to go up and then come down.”

The history of venture is full of flash-in-the-pan businesses—the pandemic briefly gave us ultrafast delivery and vaccine passport apps—but what separates the winners from the losers is the ability to expand quickly into more durable areas. In the case of food safety, the issue investors point to is a business driven by regulatory rather than epidemiological factors, a key distinction that determines where capital flows.

Sign up for The Daily Pitch newsletter

“Food companies aren’t likely to pay for additional food safety tools until a regulatory requirement makes it necessary,” said Chuck Templeton, managing partner at S2G Investments, which counts the food tracking startup SafeTraces amongst its portfolio. “That means the capital needed to build and deploy solutions at scale is unlikely to materialize on a purely voluntary basis.”

The demand an outbreak generates mostly lands in the public sector. Clear Labs CEO and co-founder Sasan Amini said that utilization of the company’s AI screening service has climbed at the public health labs of the Centers for Disease Control and Prevention and the Food and Drug Administration. Despite starting in the food safety business, Amini estimates that its screening service accounts for only somewhere in the mid-teens as a share of its business.

The key to Clear Labs’ survival has been mastering the art of the pivot while perfecting its underlying technology. The company has pivoted from food safety to COVID testing to infectious diseases and now to oncology screening.

“We’ve been opportunistic in our timing but also diversified. Public health and food become segments of the market we do serve, but they’re not the entirety of what the business does. They can’t be,” he said. “That’s how you build resiliency.”

According to Yap, tracking “bad lettuce” is a place to start a business, but it’s the development of the technology that makes the company financeable, not the mission.

“If that’s all the technology could do, is just work on one underappreciated area, that’s probably not a very good investment,” he said. “It’s good for the world, but not a very investable company.”

Learn about our editorial standards.